SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.

We applied single nucleotide polymorphism arrays (SNP-A) to study karyotypic abnormalities in patients with atypical myeloproliferative syndromes (MPD), including myeloproliferative/myelodysplastic syndrome overlap both positive and negative for the JAK2 V617F mutation and secondary acute myeloid le...

Full description

Bibliographic Details
Main Authors: Lukasz P Gondek, Andrew J Dunbar, Hadrian Szpurka, Michael A McDevitt, Jaroslaw P Maciejewski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-11-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2075364?pdf=render
_version_ 1818257677533315072
author Lukasz P Gondek
Andrew J Dunbar
Hadrian Szpurka
Michael A McDevitt
Jaroslaw P Maciejewski
author_facet Lukasz P Gondek
Andrew J Dunbar
Hadrian Szpurka
Michael A McDevitt
Jaroslaw P Maciejewski
author_sort Lukasz P Gondek
collection DOAJ
description We applied single nucleotide polymorphism arrays (SNP-A) to study karyotypic abnormalities in patients with atypical myeloproliferative syndromes (MPD), including myeloproliferative/myelodysplastic syndrome overlap both positive and negative for the JAK2 V617F mutation and secondary acute myeloid leukemia (AML). In typical MPD cases (N = 8), which served as a control group, those with a homozygous V617F mutation showed clear uniparental disomy (UPD) of 9p using SNP-A. Consistent with possible genomic instability, in 19/30 MDS/MPD-U patients, we found additional lesions not identified by metaphase cytogenetics. In addition to UPD9p, we also have detected UPD affecting other chromosomes, including 1 (2/30), 11 (4/30), 12 (1/30) and 22 (1/30). Transformation to AML was observed in 8/30 patients. In 5 V617F+ patients who progressed to AML, we show that SNP-A can allow for the detection of two modes of transformation: leukemic blasts evolving from either a wild-type jak2 precursor carrying other acquired chromosomal defects, or from a V617F+ mutant progenitor characterized by UPD9p. SNP-A-based detection of cryptic lesions in MDS/MPD-U may help explain the clinical heterogeneity of this disorder.
first_indexed 2024-12-12T17:47:27Z
format Article
id doaj.art-7a458d53621a4dea9ee624960a5b681c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T17:47:27Z
publishDate 2007-11-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7a458d53621a4dea9ee624960a5b681c2022-12-22T00:16:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032007-11-01211e122510.1371/journal.pone.0001225SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.Lukasz P GondekAndrew J DunbarHadrian SzpurkaMichael A McDevittJaroslaw P MaciejewskiWe applied single nucleotide polymorphism arrays (SNP-A) to study karyotypic abnormalities in patients with atypical myeloproliferative syndromes (MPD), including myeloproliferative/myelodysplastic syndrome overlap both positive and negative for the JAK2 V617F mutation and secondary acute myeloid leukemia (AML). In typical MPD cases (N = 8), which served as a control group, those with a homozygous V617F mutation showed clear uniparental disomy (UPD) of 9p using SNP-A. Consistent with possible genomic instability, in 19/30 MDS/MPD-U patients, we found additional lesions not identified by metaphase cytogenetics. In addition to UPD9p, we also have detected UPD affecting other chromosomes, including 1 (2/30), 11 (4/30), 12 (1/30) and 22 (1/30). Transformation to AML was observed in 8/30 patients. In 5 V617F+ patients who progressed to AML, we show that SNP-A can allow for the detection of two modes of transformation: leukemic blasts evolving from either a wild-type jak2 precursor carrying other acquired chromosomal defects, or from a V617F+ mutant progenitor characterized by UPD9p. SNP-A-based detection of cryptic lesions in MDS/MPD-U may help explain the clinical heterogeneity of this disorder.http://europepmc.org/articles/PMC2075364?pdf=render
spellingShingle Lukasz P Gondek
Andrew J Dunbar
Hadrian Szpurka
Michael A McDevitt
Jaroslaw P Maciejewski
SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
PLoS ONE
title SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
title_full SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
title_fullStr SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
title_full_unstemmed SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
title_short SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
title_sort snp array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in mds mpd u and mpd
url http://europepmc.org/articles/PMC2075364?pdf=render
work_keys_str_mv AT lukaszpgondek snparraykaryotypingallowsforthedetectionofuniparentaldisomyandcrypticchromosomalabnormalitiesinmdsmpduandmpd
AT andrewjdunbar snparraykaryotypingallowsforthedetectionofuniparentaldisomyandcrypticchromosomalabnormalitiesinmdsmpduandmpd
AT hadrianszpurka snparraykaryotypingallowsforthedetectionofuniparentaldisomyandcrypticchromosomalabnormalitiesinmdsmpduandmpd
AT michaelamcdevitt snparraykaryotypingallowsforthedetectionofuniparentaldisomyandcrypticchromosomalabnormalitiesinmdsmpduandmpd
AT jaroslawpmaciejewski snparraykaryotypingallowsforthedetectionofuniparentaldisomyandcrypticchromosomalabnormalitiesinmdsmpduandmpd